Bachem Holding AG Namens-Aktien SF 0,01

ISIN: CH1176493729 WKN: A3DLKE Marktsegment: Freiverkehr

53,90 EUR

+0,84% +0,4500

- 1d
show active - 3m
- 1y
- 3y
- 5y

Kursdaten

  • Börse Düsseldorf
  • Update 09.05.25 22:00 Uhr
  • Geld 0
  • Geld Stk. 0
  • Brief 0
  • Brief Stk. 0
  • Spread 0
  • Letzter 53,90
  • Änderung +0,84 %
  • Stand 09.05.25 19:30 Uhr
  • Eröffnung 53,50
  • Vortag 53,45
  • Gehandelt Stücke 0
  • Gehandelt Umsatz 0
  • Tageshoch 53,95
  • Tagestief 53,50

Stammdaten

  • Wertpapiertyp Stammaktien
  • ISIN CH1176493729
  • WKN A3DLKE
  • Währung EUR
  • Erstnotierung 02.05.2025

Fundamentaldaten

  • Hauptversammlung 10.04.2019
- 1d
show active - 3m
- 1y
- 3y
- 5y

Portrait

Bachem is an independent, technology-based company specializing in the production of innovative biochemical and pharmaceutical compounds and the development of manufacturing processes. Complementary services are geared to support customers from dedicated syntheses of defined target structures up to the registration of new compounds. With headquarters in Bubendorf, Switzerland, and group companies in Europe and the US, Bachem works on a global scale and holds a leading position in its field. Facilities in Switzerland and in the US, approved by international regulatory authorities and suitable also for the large scale production of active ingredients, make Bachem a partner for all major pharmaceutical companies. Based on its dedication to research, Bachem also offers opportunities to innovative technology partners for collaborations on future active substances. The company employs 575 motivated and qualified people worldwide. In its activities, Bachem is committed to its customers, employees and shareholders, as well as to the environment and society as a whole. Bachem´s contribution to the development and production of pharmaceutical compounds benefits these constituencies and contributes to secure the long-term future of the company.

Newsbox Finanznachrichten.de

Kennzahlen
(Times & Sales)
Historische Kurse